Dalane W Kitzman Selected Research

Dalane W Kitzman Research Topics

Disease

73	Heart Failure 01/2022 - 09/2002
16	Hypertension (High Blood Pressure) 10/2022 - 01/2002
14	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 08/2009
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2015
7	Albuminuria 12/2021 - 09/2015
6	Chronic Renal Insufficiency 01/2022 - 04/2011
6	Inflammation (Inflammations) 01/2020 - 11/2012
5	Obesity 01/2022 - 06/2002
5	Fibrosis (Cirrhosis) 01/2018 - 01/2008
4	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2012
4	Body Weight (Weight, Body) 01/2022 - 02/2003
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 09/2015
4	Left Ventricular Dysfunction 07/2016 - 03/2005
4	Diastolic Heart Failure 07/2009 - 04/2005
3	Overweight 10/2022 - 09/2011
3	Weight Loss (Weight Reduction) 10/2022 - 09/2011
3	Renal Insufficiency (Renal Failure) 01/2022 - 11/2019
3	Frailty 01/2021 - 01/2016
3	Chronic Kidney Failure (Chronic Renal Failure) 11/2019 - 05/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2018 - 01/2012
3	Atherosclerosis 10/2017 - 01/2015
3	Ischemia 01/2012 - 08/2006
2	Hypotension (Low Blood Pressure) 01/2021 - 06/2016
2	Syncope (Fainting) 01/2021 - 06/2016
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 06/2016
2	Dysbiosis 01/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 12/2018 - 11/2014
2	Diabetes Mellitus 11/2018 - 10/2007
2	Weight Gain 01/2018 - 09/2015
2	Neoplasms (Cancer) 01/2018 - 01/2018
2	Chronic Disease (Chronic Diseases) 01/2017 - 11/2012
2	Hypercholesterolemia 01/2015 - 02/2002
2	Atrial Fibrillation 01/2012 - 07/2009
2	Coronary Disease (Coronary Heart Disease) 07/2009 - 05/2002
1	Edema (Dropsy) 12/2021
1	Disease Progression 02/2020
1	Insulin Resistance 01/2019

Drug/Important Bio-Agent (IBA)

10	Oxygen (Dioxygen)IBA 01/2022 - 09/2008
9	AtrasentanIBA 01/2022 - 09/2015
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2009
9	CreatinineIBA 12/2021 - 07/2009
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 07/2012
5	pro-brain natriuretic peptide (1-76)IBA 12/2021 - 07/2009
5	SodiumIBA 11/2019 - 01/2002
5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 04/2005
5	Hemoglobins (Hemoglobin)IBA 01/2019 - 10/2012
5	Spironolactone (Aldactone)FDA LinkGeneric 11/2017 - 03/2009
4	Endothelin Receptor AntagonistsIBA 01/2022 - 11/2019
4	AlbuminsIBA 12/2021 - 09/2015
4	DiureticsIBA 12/2019 - 08/2006
4	Dobutamine FDA LinkGeneric 11/2018 - 08/2009
4	Mineralocorticoid Receptor AntagonistsIBA 01/2018 - 03/2009
3	C-Reactive ProteinIBA 10/2022 - 07/2009
3	Prealbumin (Transthyretin)IBA 01/2021 - 04/2006
3	CalciumIBA 01/2019 - 11/2009
3	AldosteroneIBA 01/2018 - 01/2008
3	NitratesIBA 09/2017 - 01/2016
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2013 - 08/2006
3	Angiotensin Receptor AntagonistsIBA 05/2013 - 09/2002
3	Antihypertensive Agents (Antihypertensives)IBA 01/2012 - 05/2002
2	Interleukin-6 (Interleukin 6)IBA 10/2022 - 11/2012
2	Natriuretic PeptidesIBA 01/2022 - 01/2012
2	Troponin T (Troponin T1)IBA 12/2021 - 07/2017
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021 - 01/2018
2	Isoleucine (L-Isoleucine)FDA Link 01/2021 - 01/2015
2	Valine (L-Valine)FDA Link 01/2021 - 01/2015
2	ElectrolytesIBA 01/2021 - 06/2016
2	Endothelin A ReceptorIBA 11/2019 - 05/2016
2	neladenoson bialanateIBA 01/2019 - 11/2018
2	patiromerIBA 01/2018 - 04/2011
2	AnthracyclinesIBA 01/2018 - 11/2014
2	Neprilysin (Neutral Endopeptidase)IBA 01/2018 - 07/2016
2	Cystatin CIBA 07/2017 - 07/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2016 - 01/2016
2	Adrenergic Agents (Adrenergic Drugs)IBA 02/2016 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2015
2	Galectin 3 (LGALS3)IBA 06/2014 - 01/2012
2	Irbesartan FDA LinkGeneric 09/2012 - 05/2011
2	CollagenIBA 11/2011 - 07/2009
2	FenfluramineIBA 04/2005 - 06/2002
1	dapagliflozinIBA 11/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	lipoteichoic acidIBA 01/2020
1	MucinsIBA 01/2020
1	Radioisotopes (Radionuclides)IBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2019
1	Adenosine A1 ReceptorIBA 01/2019
1	Inulin FDA Link 01/2019

Therapy/Procedure

21	Therapeutics 01/2022 - 04/2005
6	Caloric Restriction 10/2022 - 01/2016
5	Cardiac Rehabilitation 01/2019 - 12/2013
4	Secondary Prevention 01/2019 - 11/2013
3	Patient Readmission 01/2021 - 06/2016
3	Drug Therapy (Chemotherapy) 12/2018 - 11/2014
2	Home Nursing (Nursing, Home) 05/2016 - 01/2016
2	Contraindications 05/2013 - 02/2013
1	Aftercare (After-Treatment) 11/2021
1	Catheters 01/2020
1	Kidney Transplantation 11/2019